Related references
Note: Only part of the references are listed.Distribution and binding of 18F-labeled and 125I-labeled analogues of ACI-80, a prospective molecular imaging biomarker of disease: A whole hemisphere post mortem autoradiography study in human brains obtained from Alzheimer's disease patients
Balazs Gulyas et al.
NEUROCHEMISTRY INTERNATIONAL (2012)
Fluorine-18 labeling of three novel D-peptides by conjugation with N-succinimidyl-4-[18F]fluorobenzoate and preliminary examination by postmortem whole-hemisphere human brain autoradiography
Mahabuba Jahan et al.
NUCLEAR MEDICINE AND BIOLOGY (2012)
Differently Selected D-Enantiomeric Peptides Act on Different Aβ Species
Dirk Bartnik et al.
REJUVENATION RESEARCH (2010)
In vitro and in vivo Staining Characteristics of Small, Fluorescent, Aβ42-Binding D-Enantiomeric Peptides in Transgenic AD Mouse Models
Thomas van Groen et al.
CHEMMEDCHEM (2009)
Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease
Joseph L. Price et al.
NEUROBIOLOGY OF AGING (2009)
[11C]PIB-amyloid binding and levels of Aβ40 and Aβ42 in postmortem brain tissue from Alzheimer patients
Marie M. Svedberg et al.
NEUROCHEMISTRY INTERNATIONAL (2009)
Reduction of Alzheimer's Disease Amyloid Plaque Load in Transgenic Mice by D3, a D-Enantiomeric Peptide Identified by Mirror Image Phage Display
Thomas van Groen et al.
CHEMMEDCHEM (2008)
Amyloid imaging in Alzheimer's disease
Agneta Nordberg
NEUROPSYCHOLOGIA (2008)
Inhibition of cytotoxicity and amyloid fibril formation by a D-amino acid peptide that specifically binds to Alzheimer's diseaseamyloid peptide
K. Wiesehan et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2008)
Amyloid imaging in Alzheimer's disease
Agneta Nordberg
CURRENT OPINION IN NEUROLOGY (2007)
Forecasting the global burden of Alzheimer's disease
Ron Brookmeyer et al.
ALZHEIMERS & DEMENTIA (2007)
Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide
Christian Haass et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Normal and abnormal tau neurobiology
Karen Duff
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2006)
[11]PIB in a nondemented population -: Potential antecedent marker of Alzheimer disease
M. A. Mintun et al.
NEUROLOGY (2006)
Analyzing a kinetic titration series using affinity biosensors
R Karlsson et al.
ANALYTICAL BIOCHEMISTRY (2006)
Amyloidogenic processing of beta-amyloid precursor protein in intracellular compartments
KS Vetrivel et al.
NEUROLOGY (2006)
Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease?
PJ Visser et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Human salivary mucin MUC7 12-mer-L and 12-mer-D peptides: Antifungal activity in saliva, enhancement of activity with protease inhibitor cocktail or EDTA, and cytotoxicity to human cells
GX Wei et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Detection and management of cognitive impairment in primary care: The Steel Valley Seniors Survey
M Ganguli et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2004)
A synthetic peptide blocking the apolipoprotein E/β-amyloid binding mitigates β-amyloid toxicity and fibril formation in vitro and reduces β-amyloid plaques in transgenic mice
M Sadowski et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Mirror-image phage display: Aiming at the mirror
K Wiesehan et al.
CHEMBIOCHEM (2003)
Practice parameter: Diagnosis of dementia (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology
DS Knopman et al.
NEUROLOGY (2001)
The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease
TC Dickson et al.
NEUROSCIENCE (2001)
Share Paper
